Search Within

Alexander Edward Drilon

  1. "Alex Makhnin"
Formats
  1. Meeting Abstract (5)
  2. Journal Article (3)
Groups
  1. Department of Medicine (8)
  2. Solid Tumor Oncology Division (8)
  3. Thoracic Oncology (8)
  4. Department of Pathology and Laboratory Medicine (7)
  5. GSK Faculty (7)
  6. Weinberg Fellows (7)

More Groups

People
  1. Alex Makhnin (8)
  2. Bob Li (6)
  3. Charles Rudin (6)
  4. Maria Arcila (6)
  5. Michael Offin (6)
  6. Mark Kris (5)

More People

Years
  1. 2023 (1)
  2. 2021 (2)
  3. 2019 (4)
  4. 2018 (1)
Publications
  1. Journal of Clinical Oncology (2)
  2. Journal of Thoracic Oncology (2)
  3. Annals of Oncology (1)
  4. Clinical Cancer Research (1)
  5. JNCI: Journal of the National Cancer Institute (1)
  6. Lung Cancer (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. Elsevier Inc. (2)
  3. Oxford University Press (2)
  4. American Association for Cancer Research (1)
  5. Elsevier Ireland Ltd. (1)

Results (8)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II study of cabozantinib in patients with MET-altered lung cancers
    Meeting Abstract

    Harada, G.; Santini, F. C.; Repetti, R. W.; Chang, J.; Yang, S. R.; Lin, Y. T.; Moses, K. A.; Falcon, C.; Wilhelm, C. J.; Goldstein, M.; more...
    Annals of Oncology (2023)

    Fulltext@MSK | Save
  • Clinical utility of next-generation sequencing-based ctDNA testing for common and novel ALK fusions
    Journal Article

    Mondaca, S.; Lebow, E. S.; Namakydoust, A.; Razavi, P.; Reis-Filho, J. S.; Shen, R.; Offin, M.; Tu, H. Y.; Murciano-Goroff, Y.; Xu, C.; more...
    Lung Cancer (2021)

    Fulltext@MSK | Save
  • MET exon 14-altered lung cancers and MET inhibitor resistance
    Journal Article

    Guo, R.; Offin, M.; Brannon, A. R.; Chang, J.; Chow, A.; Delasos, L.; Girshman, J.; Wilkins, O.; McCarthy, C. G.; Makhnin, A.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • A phase 2 trial of cabozantinib in ROS1-rearranged lung adenocarcinoma
    Meeting Abstract

    Guo, R.; Preeshagul, I.; Schoenfeld, A.; McCarthy, C.; Makhnin, A.; Plodkowski, A.; Ginsberg, M.; Davare, M.; Delasos, L.; Somwar, R.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • A clinical utility study of plasma DNA next generation sequencing guided treatment of uncommon drivers in advanced non-small-cell lung cancers
    Meeting Abstract

    Tu, H.; Xu, C.; Tong-Li, C.; Offin, M.; Razavi, P.; Schapira, E.; Namakydoust, A.; Lee, A.; Pavlakis, N.; Clarke, S.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy of ramucirumab and docetaxel given either before or after immune checkpoint inhibitors in patients with lung cancers
    Meeting Abstract

    Offin, M.; Xu, C.; Jain, H.; Makhnin, A.; Hayes, S. A.; Plodkowski, A. J.; Halpenny, D.; Rudin, C. M.; Kris, M. G.; Drilon, A. E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A prospective study of circulating tumor DNA to guide matched targeted therapy in lung cancers
    Journal Article

    Sabari, J. K.; Offin, M.; Stephens, D.; Ni, A.; Lee, A.; Pavlakis, N.; Clarke, S.; Diakos, C. I.; Datta, S.; Tandon, N.; more...
    JNCI: Journal of the National Cancer Institute (2019)

    Fulltext@MSK | Save
  • Circulating tumor DNA in advanced lung cancers: A prospective evaluation of matched therapy and shedding detection
    Meeting Abstract

    Offin, M. D.; Stephens, D.; Sabari, J. K.; Makhnin, A.; Myers, M.; Ni, A.; Pavlakis, N.; Clarke, S. J.; Tandon, N.; Datta, S.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save